Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Clinical trial NCT00080899 · COMPLETED

Trial details

NCT number: NCT00080899
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Recurrent Prostate Cancer

Start date: 2004-06-01
Primary completion: 2009-01-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.